Correction: The Role of Interleukin−6 in Prematurity Complications: Transitioning from Biomarker to Therapeutic Target

1

The published version of Table 1 contained errors regarding AUC values and descriptions of outcomes related to IL-6 and prematurity complications.
2

Each year, 13.4 million cases of prematurity occur globally, significantly impacting the health of preterm infants and their families.
3

Interleukin−6 (IL−6) is linked to preterm labor initiation and various complications, including bronchopulmonary dysplasia and neonatal septicemia.
4

IL-6 levels peak six hours after inflammation begins, aiding in the diagnosis of early-onset neonatal sepsis more effectively than CRP.
5

The IL-6 threshold for diagnosing neonatal sepsis in preterm infants remains undetermined despite its recognized importance as a biomarker.

1